APO Research
Talk to an analyst

APO RESEARCH · REPORT

Organ Preservation Solutions

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Organ Preservation Solutions Market Analysis and Forecast 2026-2032

19 December 2025197 pages

Choose your research edition.

Industry ResearchOrgan Preservation Solutions Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Organ Preservation Solutions Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Organ Preservation Solutions Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Organ Preservation Solutions Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Organ Preservation Solutions Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Organ Preservation Solutions market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Organ Preservation Solutions is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Organ Preservation Solutions is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Organ Preservation Solutions is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Organ Preservation Solutions is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Organ Preservation Solutions include 21st Century Medicine, BioLife Solutions, Inc., BioTime, Inc., Bristol-Myers Squibb, Claris Lifesciences Limited, CryoLife, Inc., Dr. Franz Köhler Chemie, Lifeline Scientific and Teva Pharmaceutical Industries Ltd., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Organ Preservation Solutions, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Organ Preservation Solutions, also provides the revenue of main regions and countries. Of the upcoming market potential for Organ Preservation Solutions, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Organ Preservation Solutions revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Organ Preservation Solutions market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Organ Preservation Solutions revenue, projected growth trends, production technology, application and end-user industry.

Organ Preservation Solutions Segment by Company

21st Century Medicine

BioLife Solutions, Inc.

BioTime, Inc.

Bristol-Myers Squibb

Claris Lifesciences Limited

CryoLife, Inc.

Dr. Franz Köhler Chemie

Lifeline Scientific

Teva Pharmaceutical Industries Ltd.

ToleroTech, Inc

XVIVO Perfusion AB

Organ Preservation Solutions Segment by Type

Viaspan

Custodial

siRNA Transplant Solutions

Others

Organ Preservation Solutions Segment by Application

Hypothermic Perfusion Preservation (HPP)

Static Cold Storage (SCS)

Others

Organ Preservation Solutions Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Organ Preservation Solutions market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Organ Preservation Solutions and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Organ Preservation Solutions.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Organ Preservation Solutions in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Organ Preservation Solutions company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Organ Preservation Solutions revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Organ Preservation Solutions Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Viaspan Major Player Table 3. Custodial Major Player Table 4. siRNA Transplant Solutions Major Player Table 5. Others Major Player Table 6. Global Organ Preservation Solutions Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hypothermic Perfusion Preservation (HPP) Major Player Table 8. Static Cold Storage (SCS) Major Player Table 9. Others Major Player Table 10. Organ Preservation Solutions Industry Trends Table 11. Organ Preservation Solutions Industry Drivers Table 12. Organ Preservation Solutions Industry Opportunities and Challenges Table 13. Organ Preservation Solutions Industry Restraints Table 14. Global Organ Preservation Solutions Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Organ Preservation Solutions Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Organ Preservation Solutions Market Share by Region (2021-2026) Table 17. Global Organ Preservation Solutions Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Organ Preservation Solutions Market Share by Region (2027-2032) Table 19. Global Organ Preservation Solutions Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Organ Preservation Solutions Revenue Market Share by Players (2021-2026) Table 21. Global Organ Preservation Solutions Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Organ Preservation Solutions Key Players Headquarters & Area Served Table 23. Global Organ Preservation Solutions Players, Product Type & Application Table 24. Global Organ Preservation Solutions Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Organ Preservation Solutions by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Organ Preservation Solutions Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Organ Preservation Solutions Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Organ Preservation Solutions Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Organ Preservation Solutions Revenue Market Share by Type (2021-2026) Table 31. Global Organ Preservation Solutions Revenue Market Share by Type (2027-2032) Table 32. Global Organ Preservation Solutions Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Organ Preservation Solutions Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Organ Preservation Solutions Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Organ Preservation Solutions Revenue Market Share by Application (2021-2026) Table 36. Global Organ Preservation Solutions Revenue Market Share by Application (2027-2032) Table 37. 21st Century Medicine Company Information Table 38. 21st Century Medicine Business Overview Table 39. 21st Century Medicine Organ Preservation Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. 21st Century Medicine Organ Preservation Solutions Product Portfolio Table 41. 21st Century Medicine Recent Development Table 42. BioLife Solutions, Inc. Company Information Table 43. BioLife Solutions, Inc. Business Overview Table 44. BioLife Solutions, Inc. Organ Preservation Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. BioLife Solutions, Inc. Organ Preservation Solutions Product Portfolio Table 46. BioLife Solutions, Inc. Recent Development Table 47. BioTime, Inc. Company Information Table 48. BioTime, Inc. Business Overview Table 49. BioTime, Inc. Organ Preservation Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. BioTime, Inc. Organ Preservation Solutions Product Portfolio Table 51. BioTime, Inc. Recent Development Table 52. Bristol-Myers Squibb Company Information Table 53. Bristol-Myers Squibb Business Overview Table 54. Bristol-Myers Squibb Organ Preservation Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Bristol-Myers Squibb Organ Preservation Solutions Product Portfolio Table 56. Bristol-Myers Squibb Recent Development Table 57. Claris Lifesciences Limited Company Information Table 58. Claris Lifesciences Limited Business Overview Table 59. Claris Lifesciences Limited Organ Preservation Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Claris Lifesciences Limited Organ Preservation Solutions Product Portfolio Table 61. Claris Lifesciences Limited Recent Development Table 62. CryoLife, Inc. Company Information Table 63. CryoLife, Inc. Business Overview Table 64. CryoLife, Inc. Organ Preservation Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. CryoLife, Inc. Organ Preservation Solutions Product Portfolio Table 66. CryoLife, Inc. Recent Development Table 67. Dr. Franz Köhler Chemie Company Information Table 68. Dr. Franz Köhler Chemie Business Overview Table 69. Dr. Franz Köhler Chemie Organ Preservation Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Dr. Franz Köhler Chemie Organ Preservation Solutions Product Portfolio Table 71. Dr. Franz Köhler Chemie Recent Development Table 72. Lifeline Scientific Company Information Table 73. Lifeline Scientific Business Overview Table 74. Lifeline Scientific Organ Preservation Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Lifeline Scientific Organ Preservation Solutions Product Portfolio Table 76. Lifeline Scientific Recent Development Table 77. Teva Pharmaceutical Industries Ltd. Company Information Table 78. Teva Pharmaceutical Industries Ltd. Business Overview Table 79. Teva Pharmaceutical Industries Ltd. Organ Preservation Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Teva Pharmaceutical Industries Ltd. Organ Preservation Solutions Product Portfolio Table 81. Teva Pharmaceutical Industries Ltd. Recent Development Table 82. ToleroTech, Inc Company Information Table 83. ToleroTech, Inc Business Overview Table 84. ToleroTech, Inc Organ Preservation Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. ToleroTech, Inc Organ Preservation Solutions Product Portfolio Table 86. ToleroTech, Inc Recent Development Table 87. XVIVO Perfusion AB Company Information Table 88. XVIVO Perfusion AB Business Overview Table 89. XVIVO Perfusion AB Organ Preservation Solutions Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. XVIVO Perfusion AB Organ Preservation Solutions Product Portfolio Table 91. XVIVO Perfusion AB Recent Development Table 92. North America Organ Preservation Solutions Revenue by Type (2021-2026) & (US$ Million) Table 93. North America Organ Preservation Solutions Revenue by Type (2027-2032) & (US$ Million) Table 94. North America Organ Preservation Solutions Revenue by Application (2021-2026) & (US$ Million) Table 95. North America Organ Preservation Solutions Revenue by Application (2027-2032) & (US$ Million) Table 96. North America Organ Preservation Solutions Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 97. North America Organ Preservation Solutions Revenue by Country (2021-2026) & (US$ Million) Table 98. North America Organ Preservation Solutions Revenue by Country (US$ Million) & (2027-2032) Table 99. Europe Organ Preservation Solutions Revenue by Type (2021-2026) & (US$ Million) Table 100. Europe Organ Preservation Solutions Revenue by Type (2027-2032) & (US$ Million) Table 101. Europe Organ Preservation Solutions Revenue by Application (2021-2026) & (US$ Million) Table 102. Europe Organ Preservation Solutions Revenue by Application (2027-2032) & (US$ Million) Table 103. Europe Organ Preservation Solutions Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 104. Europe Organ Preservation Solutions Revenue by Country (2021-2026) & (US$ Million) Table 105. Europe Organ Preservation Solutions Revenue by Country (US$ Million) & (2027-2032) Table 106. China Organ Preservation Solutions Revenue by Type (2021-2026) & (US$ Million) Table 107. China Organ Preservation Solutions Revenue by Type (2027-2032) & (US$ Million) Table 108. China Organ Preservation Solutions Revenue by Application (2021-2026) & (US$ Million) Table 109. China Organ Preservation Solutions Revenue by Application (2027-2032) & (US$ Million) Table 110. Asia Organ Preservation Solutions Revenue by Type (2021-2026) & (US$ Million) Table 111. Asia Organ Preservation Solutions Revenue by Type (2027-2032) & (US$ Million) Table 112. Asia Organ Preservation Solutions Revenue by Application (2021-2026) & (US$ Million) Table 113. Asia Organ Preservation Solutions Revenue by Application (2027-2032) & (US$ Million) Table 114. Asia Organ Preservation Solutions Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 115. Asia Organ Preservation Solutions Revenue by Region (US$ Million) & (2021-2026) Table 116. Asia Organ Preservation Solutions Revenue by Region (US$ Million) & (2027-2032) Table 117. SAMEA Organ Preservation Solutions Revenue by Type (2021-2026) & (US$ Million) Table 118. SAMEA Organ Preservation Solutions Revenue by Type (2027-2032) & (US$ Million) Table 119. SAMEA Organ Preservation Solutions Revenue by Application (2021-2026) & (US$ Million) Table 120. SAMEA Organ Preservation Solutions Revenue by Application (2027-2032) & (US$ Million) Table 121. SAMEA Organ Preservation Solutions Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. SAMEA Organ Preservation Solutions Revenue by Country (2021-2026) & (US$ Million) Table 123. SAMEA Organ Preservation Solutions Revenue by Country (US$ Million) & (2027-2032) Table 124. Research Programs/Design for This Report Table 125. Authors List of This Report Table 126. Secondary Sources Table 127. Primary Sources List of Figures Figure 1. Organ Preservation Solutions Image Figure 2. Global Organ Preservation Solutions Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Organ Preservation Solutions Market Size Share 2021 VS 2025 VS 2032 Figure 4. Viaspan Image Figure 5. Custodial Image Figure 6. siRNA Transplant Solutions Image Figure 7. Others Image Figure 8. Global Organ Preservation Solutions Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Organ Preservation Solutions Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hypothermic Perfusion Preservation (HPP) Image Figure 11. Static Cold Storage (SCS) Image Figure 12. Others Image Figure 13. Global Organ Preservation Solutions Market Size (US$ Million) & (2021-2032) Figure 14. Global Organ Preservation Solutions Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Organ Preservation Solutions Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Organ Preservation Solutions Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Organ Preservation Solutions Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Organ Preservation Solutions Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Organ Preservation Solutions Revenue Market Share by Type (2021-2032) Figure 21. Global Organ Preservation Solutions Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Organ Preservation Solutions Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Organ Preservation Solutions Revenue Market Share by Application (2021-2032) Figure 24. North America Organ Preservation Solutions Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Organ Preservation Solutions Revenue Share by Type (2021-2032) Figure 26. North America Organ Preservation Solutions Revenue Share by Application (2021-2032) Figure 27. North America Organ Preservation Solutions Revenue Share by Country (2021-2032) Figure 28. United States Organ Preservation Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Organ Preservation Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Organ Preservation Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Organ Preservation Solutions Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Organ Preservation Solutions Revenue Share by Type (2021-2032) Figure 33. Europe Organ Preservation Solutions Revenue Share by Application (2021-2032) Figure 34. Europe Organ Preservation Solutions Revenue Share by Country (2021-2032) Figure 35. Germany Organ Preservation Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Organ Preservation Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Organ Preservation Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Organ Preservation Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Organ Preservation Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Organ Preservation Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Organ Preservation Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Organ Preservation Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Organ Preservation Solutions Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Organ Preservation Solutions Revenue Share by Type (2021-2032) Figure 45. China Organ Preservation Solutions Revenue Share by Application (2021-2032) Figure 46. Asia Organ Preservation Solutions Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Organ Preservation Solutions Revenue Share by Type (2021-2032) Figure 48. Asia Organ Preservation Solutions Revenue Share by Application (2021-2032) Figure 49. Asia Organ Preservation Solutions Revenue Share by Region (2021-2032) Figure 50. Japan Organ Preservation Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Organ Preservation Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Organ Preservation Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Organ Preservation Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Organ Preservation Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Organ Preservation Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Organ Preservation Solutions Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Organ Preservation Solutions Revenue Share by Type (2021-2032) Figure 58. SAMEA Organ Preservation Solutions Revenue Share by Application (2021-2032) Figure 59. SAMEA Organ Preservation Solutions Revenue Share by Country (2021-2032) Figure 60. Brazil Organ Preservation Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Organ Preservation Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Organ Preservation Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Organ Preservation Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Organ Preservation Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Organ Preservation Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Organ Preservation Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Organ Preservation Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Organ Preservation Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Organ Preservation Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Organ Preservation Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Viaspan
  • Custodial
  • siRNA Transplant Solutions
  • Others
Applications
  • Hypothermic Perfusion Preservation (HPP)
  • Static Cold Storage (SCS)
  • Others
Companies covered
  • 21st Century Medicine
  • BioLife Solutions, Inc.
  • BioTime, Inc.
  • Bristol-Myers Squibb
  • Claris Lifesciences Limited
  • CryoLife, Inc.
  • Dr. Franz Köhler Chemie
  • Lifeline Scientific
  • Teva Pharmaceutical Industries Ltd.
  • ToleroTech, Inc
  • XVIVO Perfusion AB

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Organ Preservation Solutions Market by Type
  3. 1.2.1 Global Organ Preservation Solutions Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Viaspan
  5. 1.2.3 Custodial
  6. 1.2.4 siRNA Transplant Solutions
  7. 1.2.5 Others
  8. 1.3 Organ Preservation Solutions Market by Application
  9. 1.3.1 Global Organ Preservation Solutions Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hypothermic Perfusion Preservation (HPP)
  11. 1.3.3 Static Cold Storage (SCS)
  12. 1.3.4 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Organ Preservation Solutions Market Dynamics
  1. 2.1 Organ Preservation Solutions Industry Trends
  2. 2.2 Organ Preservation Solutions Industry Drivers
  3. 2.3 Organ Preservation Solutions Industry Opportunities and Challenges
  4. 2.4 Organ Preservation Solutions Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Organ Preservation Solutions Market Perspective (2021-2032)
  2. 3.2 Global Organ Preservation Solutions Growth Trends by Region
  3. 3.2.1 Global Organ Preservation Solutions Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Organ Preservation Solutions Market Size by Region (2021-2026)
  5. 3.2.3 Global Organ Preservation Solutions Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Organ Preservation Solutions Revenue by Players
  2. 4.1.1 Global Organ Preservation Solutions Revenue by Players (2021-2026)
  3. 4.1.2 Global Organ Preservation Solutions Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Organ Preservation Solutions Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Organ Preservation Solutions Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Organ Preservation Solutions Key Players Headquarters & Area Served
  7. 4.4 Global Organ Preservation Solutions Players, Product Type & Application
  8. 4.5 Global Organ Preservation Solutions Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Organ Preservation Solutions Market CR5 and HHI
  11. 4.6.3 2025 Organ Preservation Solutions Tier 1, Tier 2, and Tier 3
5 Organ Preservation Solutions Market Size by Type
  1. 5.1 Global Organ Preservation Solutions Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Organ Preservation Solutions Revenue by Type (2021-2032)
  3. 5.3 Global Organ Preservation Solutions Revenue Market Share by Type (2021-2032)
6 Organ Preservation Solutions Market Size by Application
  1. 6.1 Global Organ Preservation Solutions Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Organ Preservation Solutions Revenue by Application (2021-2032)
  3. 6.3 Global Organ Preservation Solutions Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 21st Century Medicine
  2. 7.1.1 21st Century Medicine Company Information
  3. 7.1.2 21st Century Medicine Business Overview
  4. 7.1.3 21st Century Medicine Organ Preservation Solutions Revenue and Gross Margin (2021-2026)
  5. 7.1.4 21st Century Medicine Organ Preservation Solutions Product Portfolio
  6. 7.1.5 21st Century Medicine Recent Developments
  7. 7.2 BioLife Solutions, Inc.
  8. 7.2.1 BioLife Solutions, Inc. Company Information
  9. 7.2.2 BioLife Solutions, Inc. Business Overview
  10. 7.2.3 BioLife Solutions, Inc. Organ Preservation Solutions Revenue and Gross Margin (2021-2026)
  11. 7.2.4 BioLife Solutions, Inc. Organ Preservation Solutions Product Portfolio
  12. 7.2.5 BioLife Solutions, Inc. Recent Developments
  13. 7.3 BioTime, Inc.
  14. 7.3.1 BioTime, Inc. Company Information
  15. 7.3.2 BioTime, Inc. Business Overview
  16. 7.3.3 BioTime, Inc. Organ Preservation Solutions Revenue and Gross Margin (2021-2026)
  17. 7.3.4 BioTime, Inc. Organ Preservation Solutions Product Portfolio
  18. 7.3.5 BioTime, Inc. Recent Developments
  19. 7.4 Bristol-Myers Squibb
  20. 7.4.1 Bristol-Myers Squibb Company Information
  21. 7.4.2 Bristol-Myers Squibb Business Overview
  22. 7.4.3 Bristol-Myers Squibb Organ Preservation Solutions Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Bristol-Myers Squibb Organ Preservation Solutions Product Portfolio
  24. 7.4.5 Bristol-Myers Squibb Recent Developments
  25. 7.5 Claris Lifesciences Limited
  26. 7.5.1 Claris Lifesciences Limited Company Information
  27. 7.5.2 Claris Lifesciences Limited Business Overview
  28. 7.5.3 Claris Lifesciences Limited Organ Preservation Solutions Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Claris Lifesciences Limited Organ Preservation Solutions Product Portfolio
  30. 7.5.5 Claris Lifesciences Limited Recent Developments
  31. 7.6 CryoLife, Inc.
  32. 7.6.1 CryoLife, Inc. Company Information
  33. 7.6.2 CryoLife, Inc. Business Overview
  34. 7.6.3 CryoLife, Inc. Organ Preservation Solutions Revenue and Gross Margin (2021-2026)
  35. 7.6.4 CryoLife, Inc. Organ Preservation Solutions Product Portfolio
  36. 7.6.5 CryoLife, Inc. Recent Developments
  37. 7.7 Dr. Franz Köhler Chemie
  38. 7.7.1 Dr. Franz Köhler Chemie Company Information
  39. 7.7.2 Dr. Franz Köhler Chemie Business Overview
  40. 7.7.3 Dr. Franz Köhler Chemie Organ Preservation Solutions Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Dr. Franz Köhler Chemie Organ Preservation Solutions Product Portfolio
  42. 7.7.5 Dr. Franz Köhler Chemie Recent Developments
  43. 7.8 Lifeline Scientific
  44. 7.8.1 Lifeline Scientific Company Information
  45. 7.8.2 Lifeline Scientific Business Overview
  46. 7.8.3 Lifeline Scientific Organ Preservation Solutions Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Lifeline Scientific Organ Preservation Solutions Product Portfolio
  48. 7.8.5 Lifeline Scientific Recent Developments
  49. 7.9 Teva Pharmaceutical Industries Ltd.
  50. 7.9.1 Teva Pharmaceutical Industries Ltd. Company Information
  51. 7.9.2 Teva Pharmaceutical Industries Ltd. Business Overview
  52. 7.9.3 Teva Pharmaceutical Industries Ltd. Organ Preservation Solutions Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Teva Pharmaceutical Industries Ltd. Organ Preservation Solutions Product Portfolio
  54. 7.9.5 Teva Pharmaceutical Industries Ltd. Recent Developments
  55. 7.10 ToleroTech, Inc
  56. 7.10.1 ToleroTech, Inc Company Information
  57. 7.10.2 ToleroTech, Inc Business Overview
  58. 7.10.3 ToleroTech, Inc Organ Preservation Solutions Revenue and Gross Margin (2021-2026)
  59. 7.10.4 ToleroTech, Inc Organ Preservation Solutions Product Portfolio
  60. 7.10.5 ToleroTech, Inc Recent Developments
  61. 7.11 XVIVO Perfusion AB
  62. 7.11.1 XVIVO Perfusion AB Company Information
  63. 7.11.2 XVIVO Perfusion AB Business Overview
  64. 7.11.3 XVIVO Perfusion AB Organ Preservation Solutions Revenue and Gross Margin (2021-2026)
  65. 7.11.4 XVIVO Perfusion AB Organ Preservation Solutions Product Portfolio
  66. 7.11.5 XVIVO Perfusion AB Recent Developments
8 North America
  1. 8.1 North America Organ Preservation Solutions Revenue (2021-2032)
  2. 8.2 North America Organ Preservation Solutions Revenue by Type (2021-2032)
  3. 8.2.1 North America Organ Preservation Solutions Revenue by Type (2021-2026)
  4. 8.2.2 North America Organ Preservation Solutions Revenue by Type (2027-2032)
  5. 8.3 North America Organ Preservation Solutions Revenue Share by Type (2021-2032)
  6. 8.4 North America Organ Preservation Solutions Revenue by Application (2021-2032)
  7. 8.4.1 North America Organ Preservation Solutions Revenue by Application (2021-2026)
  8. 8.4.2 North America Organ Preservation Solutions Revenue by Application (2027-2032)
  9. 8.5 North America Organ Preservation Solutions Revenue Share by Application (2021-2032)
  10. 8.6 North America Organ Preservation Solutions Revenue by Country
  11. 8.6.1 North America Organ Preservation Solutions Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Organ Preservation Solutions Revenue by Country (2021-2026)
  13. 8.6.3 North America Organ Preservation Solutions Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Organ Preservation Solutions Revenue (2021-2032)
  2. 9.2 Europe Organ Preservation Solutions Revenue by Type (2021-2032)
  3. 9.2.1 Europe Organ Preservation Solutions Revenue by Type (2021-2026)
  4. 9.2.2 Europe Organ Preservation Solutions Revenue by Type (2027-2032)
  5. 9.3 Europe Organ Preservation Solutions Revenue Share by Type (2021-2032)
  6. 9.4 Europe Organ Preservation Solutions Revenue by Application (2021-2032)
  7. 9.4.1 Europe Organ Preservation Solutions Revenue by Application (2021-2026)
  8. 9.4.2 Europe Organ Preservation Solutions Revenue by Application (2027-2032)
  9. 9.5 Europe Organ Preservation Solutions Revenue Share by Application (2021-2032)
  10. 9.6 Europe Organ Preservation Solutions Revenue by Country
  11. 9.6.1 Europe Organ Preservation Solutions Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Organ Preservation Solutions Revenue by Country (2021-2026)
  13. 9.6.3 Europe Organ Preservation Solutions Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
  19. 9.6.9 Nordic Countries
10 China
  1. 10.1 China Organ Preservation Solutions Revenue (2021-2032)
  2. 10.2 China Organ Preservation Solutions Revenue by Type (2021-2032)
  3. 10.2.1 China Organ Preservation Solutions Revenue by Type (2021-2026)
  4. 10.2.2 China Organ Preservation Solutions Revenue by Type (2027-2032)
  5. 10.3 China Organ Preservation Solutions Revenue Share by Type (2021-2032)
  6. 10.4 China Organ Preservation Solutions Revenue by Application (2021-2032)
  7. 10.4.1 China Organ Preservation Solutions Revenue by Application (2021-2026)
  8. 10.4.2 China Organ Preservation Solutions Revenue by Application (2027-2032)
  9. 10.5 China Organ Preservation Solutions Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Organ Preservation Solutions Revenue (2021-2032)
  2. 11.2 Asia Organ Preservation Solutions Revenue by Type (2021-2032)
  3. 11.2.1 Asia Organ Preservation Solutions Revenue by Type (2021-2026)
  4. 11.2.2 Asia Organ Preservation Solutions Revenue by Type (2027-2032)
  5. 11.3 Asia Organ Preservation Solutions Revenue Share by Type (2021-2032)
  6. 11.4 Asia Organ Preservation Solutions Revenue by Application (2021-2032)
  7. 11.4.1 Asia Organ Preservation Solutions Revenue by Application (2021-2026)
  8. 11.4.2 Asia Organ Preservation Solutions Revenue by Application (2027-2032)
  9. 11.5 Asia Organ Preservation Solutions Revenue Share by Application (2021-2032)
  10. 11.6 Asia Organ Preservation Solutions Revenue by Country
  11. 11.6.1 Asia Organ Preservation Solutions Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Organ Preservation Solutions Revenue by Country (2021-2026)
  13. 11.6.3 Asia Organ Preservation Solutions Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Organ Preservation Solutions Revenue (2021-2032)
  2. 12.2 SAMEA Organ Preservation Solutions Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Organ Preservation Solutions Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Organ Preservation Solutions Revenue by Type (2027-2032)
  5. 12.3 SAMEA Organ Preservation Solutions Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Organ Preservation Solutions Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Organ Preservation Solutions Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Organ Preservation Solutions Revenue by Application (2027-2032)
  9. 12.5 SAMEA Organ Preservation Solutions Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Organ Preservation Solutions Revenue by Country
  11. 12.6.1 SAMEA Organ Preservation Solutions Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Organ Preservation Solutions Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Organ Preservation Solutions Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst